Clinical investigation of medicinal products for the treatment of multiple sclerosis

Current effective version

PDF iconRevision 2 - Adopted guideline

Reference numberCHMP/771815/2011 Rev. 2
Published31/03/2015
Effective from01/10/2015
KeywordsMultiple sclerosis, neurological disease
DescriptionThis document provides guidance on the evaluation of medicinal products for the treatment of multiple sclerosis. It primarily focuses on treatments aimed to modify disease progression. In addition it concerns the treatment of relapses, repair and restoration of functioning and symptomatic improvement.


Document history

Revision 2

Current version

PDF iconAdopted guideline


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/10/2015–present


Published: 09/10/2012


Published: 08/07/2011

Revision 1

PDF iconAdopted guideline


PDF iconOverview of comments


PDF iconDraft guideline

In operation: 01/06/2007–30/09/2015


Published: 16/11/2006


Published: 15/09/2005


Related content


How useful was this page?

Add your rating